HDL cholesterol efflux capacity and incident cardiovascular events.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  New England Journal of Medicine

• Publication date

  2014-12-17

• Fields of study

  Medicine

• Identifiers
  DOI 10.1056/NEJMoa1409065PMID 25404125PMCID PMC4308988
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Effects of extended-release niacin with laropiprant in high-risk patients.

  2014cited by this paper
• 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults: A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines

  2014cited by this paper
• Reprint: 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.

  2014cited by this paper
• Paradoxical Association of Enhanced Cholesterol Efflux With Increased Incident Cardiovascular Risks

  2013cited by this paper
• Cholesterol efflux capacity: full steam ahead or a bump in the road?

  2013cited by this paper
• Cholesterol efflux in megakaryocyte progenitors suppresses platelet production and thrombocytosis

  2013cited by this paper
• Abdominal aortic atherosclerosis at MR imaging is associated with cardiovascular events: the Dallas heart study.

  2013cited by this paper
• Scavenger Receptor Class B Type I Is a Plasma Membrane Cholesterol Sensor

  2013cited by this paper
• Cholesterol Efflux Capacity, High-Density Lipoprotein Function, and Atherosclerosis

  2012cited by this paper
• Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

  2012cited by this paper
• Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study

  2012cited by this paper
• Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport.

  2012cited by this paper
• Effects of dalcetrapib in patients with a recent acute coronary syndrome.

  2012cited by this paper
• A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol

  2011cited by this paper
• Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis.

  2011cited by this paper
• Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers

  2011cited by this paper
• Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

  2011cited by this paper
• The Ability to Promote Efflux Via ABCA1 Determines the Capacity of Serum Specimens With Similar High-Density Lipoprotein Cholesterol to Remove Cholesterol From Macrophages

  2010cited by this paper
• The role of reverse cholesterol transport in animals and humans and relationship to atherosclerosis This work was supported by P01-HL22633 from the NHLBI. Published, JLR Papers in Press, December 8, 2008.

  2009cited by this paper
• Reconstituted High-Density Lipoprotein Attenuates Platelet Function in Individuals With Type 2 Diabetes Mellitus by Promoting Cholesterol Efflux

  2009cited by this paper
• Criteria for Evaluation of Novel Markers of Cardiovascular Risk: A Scientific Statement From the American Heart Association

  2009cited by this paper
• Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond

  2008cited by this paper
• Beyond high-density lipoprotein cholesterol levels evaluating high-density lipoprotein function as influenced by novel therapeutic approaches.

  2008cited by this paper
• Effects of torcetrapib in patients at high risk for coronary events.

  2007cited by this paper
• Decreased Atherosclerosis in Low-Density Lipoprotein Receptor Knockout Mice Transplanted With Abcg1−/− Bone Marrow

  2006cited by this paper
• Impaired Development of Atherosclerosis in Hyperlipidemic Ldlr−/− and ApoE−/− Mice Transplanted With Abcg1−/− Bone Marrow

  2006cited by this paper
• Diagnosis and Management of the Metabolic Syndrome: An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement

  2005cited by this paper
• Diagnosis and management of the metabolic syndrome

  2005cited by this paper
• Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement.

  2005cited by this paper
• Cholesterol binding, efflux, and a PDZ-interacting domain of scavenger receptor-BI mediate HDL-initiated signaling.

  2005cited by this paper
• Prognostic/Clinical Prediction Models: Multivariable Prognostic Models: Issues in Developing Models, Evaluating Assumptions and Adequacy, and Measuring and Reducing Errors

  2005cited by this paper
• African Americans and Caucasians have a similar prevalence of coronary calcium in the Dallas Heart Study.

  2004cited by this paper
• The Dallas Heart Study: a population-based probability sample for the multidisciplinary study of ethnic differences in cardiovascular health.

  2004cited by this paper

• Association of High-Density Lipoprotein Cholesterol with Macular Structure in Nonglaucomatous Individuals

  2026cites this paper
• Monocyte-to-HDL ratio (MHR) is associated with overall and renal mortality in community-dwelling older individuals with chronic kidney disease (CKD)

  2026cites this paper
• 3-Hydroxystearic acid promotes cholesterol efflux and attenuates atherosclerosis via the ALKBH5/PAX-8/ABCA1 pathway

  2026cites this paper
• HDL Regulates TGFβ-Receptor Lipid Raft Partitioning, Restoring Contractile Features of Cholesterol-Loaded Vascular Smooth Muscle Cells.

  2026cites this paper
• Associations between neutrophil-to-high-density lipoprotein cholesterol ratio and albuminuria: A cross-sectional study

  2026cites this paper
• Apolipoprotein M: Structural Insights, Functional Roles and Therapeutic Approaches in Vascular Disease.

  2026cites this paper
• Postoperative Stress Accelerates Atherosclerosis Through Inflammatory Remodeling of the HDL Proteome and Impaired Reverse Cholesterol Transport.

  2026cites this paper
• Surfactant Protein B and the Lung–HDL–Vascular Axis: Linking Pulmonary Injury to Cardiovascular Risk

  2026cites this paper
• Serum high-density lipoprotein cholesterol uptake capacity and cardiovascular risk in subjects from the Birjand longitudinal aging study

  2026cites this paper
• Prospective evaluation of chemotherapy-induced dyslipidemia in early breast cancer: implications for cardiovascular risk

  2026cites this paper
• Association Between High-Density Lipoprotein Characteristics and Hemostatic Parameters in the Netherlands Epidemiology of Obesity (NEO) Study—Brief Report

  2026cites this paper
• Association Between High-Density Lipoprotein Cholesterol Levels and Prognoses in Patients With Stroke.

  2026cites this paper
• Cholesterol Uptake Capacity as a Prognostic Marker of Cardiovascular Events for Patients with Coronary Artery Disease.

  2026influential citation
• High-Density Lipoprotein Particles, Inflammation, and Coronary Heart Disease Risk

  2025cites this paper
• High-Density Lipoprotein Dysfunction and Atherosclerotic Cardiovascular Disease: From Quantity to Quality.

  2025cites this paper
• Cholesterol uptake capacity of HDL in culture medium of fresh primary human hepatocytes: an in vitro system for screening anti-atherosclerosis drugs focused on HDL functions

  2025cites this paper
• Obicetrapib: A Novel Cholesterol Ester Transfer Protein Inhibitor.

  2025cites this paper
• Effect of ANGPTL3 Inhibition With Solbinsiran in Preclinical and Early Human Studies.

  2025cites this paper
• Vitaphospholip® (water-soluble phosphatidylcholine) in the treatment of combined hyperlipidemia: a randomized, placebo-controlled clinical trial.

  2025cites this paper
• Metabolic and functional aspects of high-density lipoproteins (HDL) in familial hypercholesterolemia with or without subclinical coronary atherosclerosis.

  2025cites this paper
• Enhanced immune recovery with B/F/TAF compared with DTG/3TC in HIV patients: A prospective observational study.

  2025cites this paper
• Little Evidence of Atherosclerosis in a Middle-Aged Japanese Woman with Familial Hypercholesterolemia Carrying PCSK9 (p.Glu32Lys) and ABCG8 (p.Ile419Asn) Variants Despite Elevated Lipoprotein(a) Levels.

  2025cites this paper
• Impact of Glucose Metabolism Status on the Association between Apolipoprotein A-I and Ischemic Risk in Patients with Coronary Artery Disease: A Large-Sample Cohort Study

  2025cites this paper
• Association Between High-Density Lipoprotein Cholesterol and the Risk of Cardiovascular Disorders: A Cohort Study of Healthy Adults.

  2025cites this paper
• Research on coronary heart disease risk factors based on Bayesian network: a cross-sectional survey of 129,155 individuals

  2025cites this paper
• Dysfunctional high-density lipoprotein: an updated review

  2025cites this paper
• The Role of Exercise-Based Cardiac Rehabilitation After Myocardial Infarction on Cholesterol Transfer to HDL

  2025influential citation
• Casz1 and Znf101/Zfp961 differentially regulate apolipoproteins A1 and B, alter plasma lipoproteins, and reduce atherosclerosis

  2025cites this paper
• Potential causal evidence for an ApoB-independent and HDL-related risk profile associated with coronary artery disease

  2025influential citation
• U-shaped Relationship between high-density lipoprotein cholesterol levels and intracranial aneurysm rupture: a retrospective cross-sectional study in the Chinese population

  2025cites this paper
• HDL from 36-h fasted participants potently promotes efflux of cholesteryl ester from activated microglia

  2025cites this paper
• Itaconate alleviates cholesterol burden via ABCA1 stabilization and cholesterol efflux.

  2025cites this paper
• Apolipoprotein A-I Infusions in Coronary Artery Disease: A Systematic Review.

  2025cites this paper
• Cholesterol efflux in HIV-associated atherosclerosis: mechanisms and targets.

  2025cites this paper
• Clinical remission in newly diagnosed type 1 diabetes mellitus and HDL function on cholesterol efflux capacity: prospective InLipoDiab1 study

  2025cites this paper
• High-density lipoprotein particles are associated with the risk of mortality from all-causes and cardiovascular diseases (CVDs) in patients with CVD: a systematic review and meta-analysis study

  2025cites this paper
• High-density lipoproteins, Part 1. Epidemiology, antiatherogenic effects, and therapies designed to increase their serum levels

  2025cites this paper
• High-density lipoprotein in cardiovascular diseases: From high quantity to high quality.

  2025cites this paper
• HDL-C: Helpful, harmful, hopeful, or guilty by association.

  2025cites this paper
• How can cholesterol efflux capacity be used as a risk factor for atherosclerotic cardiovascular disease?

  2025influential citation
• Abnormal Serum Lipid Levels and Ocular Metabolic Mediators in Adult‐Onset Myopia: A Cohort Study

  2025cites this paper
• Estimating the burden of adult diabetes in China: a systematic review and meta-analysis with attributable risk assessment

  2025cites this paper
• Metabolic Vulnerability Index and Atherosclerosis Incident: A Prospective Cohort Study From the UK Biobank

  2025cites this paper
• HDL dysfunction: a role in the pathogenesis of cardiometabolic syndrome in chronic HIV infection?

  2025cites this paper
• Obicetrapib for dyslipidemia with or without cardiovascular risk: A GRADE‐assessed meta‐analysis of randomized trials with trial sequential evidence

  2025cites this paper
• Not Just How Low, But How Stable　- Lipid Variability and Peripheral Artery Disease.

  2025cites this paper
• Exosomal non-coding RNAs: key regulators of inflammation-related cardiovascular disorders

  2025cites this paper
• High Density Lipoprotein Particle Composition, Functionality, Deficiency, and Atherosclerotic Cardiovascular Disease Risk: A Review

  2025cites this paper
• Childhood HDL-C and Adult ASCVD: Mechanistic Insights and Preventive Implications.

  2025cites this paper
• Plasma levels of small HDL particles are associated with coronary atherosclerosis progression in adults with diabetes.

  2025cites this paper
• Impact of a Chokeberry (Aronia melanocarpa (Michx.) Elliott) Supplementation on Cardiometabolic Outcomes: A Critical Systematic Review and Meta-Analysis of Randomized Controlled Trials

  2025cites this paper
• Real-World Assessment of the Association Between PCSK9i Adherence and LDL Reduction and Variability in a Chinese Clinical Practice

  2025cites this paper
• Beyond High-density Lipoprotein-cholesterol: Unraveling the Complexity of High-density Lipoprotein Functionality

  2025cites this paper
• Precision approach in apoA-I infusion trials: When CSL112 may actually work.

  2025cites this paper
• A Comprehensive Review of the Genetics of Dyslipidemias and Risk of Atherosclerotic Cardiovascular Disease

  2025cites this paper
• Cholesterol Uptake Capacity as a Prognostic Marker of Cardiovascular Events for Patients with Coronary Artery Disease

  2025influential citation
• Safety and efficacy of lamivudine/dolutegravir vs. bictegravir/emtricitabine/tenofovir alafenamide in antiretroviral-naive adults with HIV-1 infection in Shanghai, China: a single-centre retrospective study

  2025cites this paper
• ApoA-I dissociated from human HDL retains its acceptor properties in ABCA1-mediated cholesterol efflux from RAW 264.7 macrophages in coronary artery disease

  2025cites this paper
• Proatherogenic changes in the quantity and quality of lipoproteins in adults with idiopathic nephrotic syndrome.

  2025cites this paper
• The association of childhood HDL cholesterol with atherosclerotic CVD events in adults: findings from the International Childhood Cardiovascular Cohort Consortium.

  2025cites this paper
• Association of Achilles tendon thickness with lipid profile and carotid IMT in patients with familial hypercholesterolemia.

  2025cites this paper
• Effects of exercise combined with different dietary interventions on cardiovascular health a systematic review and network meta-analysis

  2025cites this paper
• Caveolin-1-mediated LDL transcytosis across endothelial cells in atherosclerosis.

  2025cites this paper
• High density lipoprotein particle size and function associate with new cardiovascular events in patients with chronic kidney disease

  2025cites this paper
• Lomitapide modifies high-density lipoprotein function in homozygous familial hypercholesterolaemia

  2025cites this paper
• Lifestyle risk factors and stroke: findings from the national health and nutrition examination survey (1999–2020) and a Mendelian randomization analysis

  2025cites this paper
• Roles of HDL function and sphingosine-1-phosphate in vasospastic angina.

  2025cites this paper
• Postoperative Stress Accelerates Atherosclerosis through Inflammatory Remodeling of the HDL Proteome and Impaired Reverse Cholesterol Transport

  2025cites this paper
• Exploring the Links Between Micronutrients and Cardiac Traits: Roles of Vitamins A1, B9, and D

  2025cites this paper
• Regulation of HDL dysfunctionality by phosphatidylethanolamine links poly-unsaturated fatty acids with atherosclerotic cardiovascular diseases

  2025cites this paper
• Evolutionary patterns and research frontiers of macrophages in myocardial infarction: A bibliometric analysis

  2025cites this paper
• Serum Tsukushi level is negatively associated with cholesterol efflux capacity in metabolic dysfunction-associated steatotic liver disease: a cross-sectional study

  2025cites this paper
• Associations of Metal Mixtures with Lipid Profiles: Exploring the Mediating Role of Testosterone in a Cross-Sectional Study.

  2025cites this paper
• Reverse cholesterol transport: current assay methods, alterations with disease and response to therapeutic intervention

  2025cites this paper
• HDL proteome: from its characterization to quantitative measurements in particle subspecies and functional associations

  2025cites this paper
• HDL Function Versus Small Dense LDL: Cardiovascular Benefits and Implications

  2025cites this paper
• Targeting the Opioid System in Cardiovascular Disease: Liver Proteomic and Lipid Profile Effects of Naloxone in Atherosclerosis

  2025cites this paper
• Improving cardiovascular risk stratification: the role of abdominal obesity in predicting MACEs

  2025cites this paper
• Maternal lipids in overweight and obesity: implications for pregnancy outcomes and offspring’s body composition

  2025cites this paper
• HDL metabolism and function in diabetes mellitus

  2025cites this paper
• Relationship of fractalkine with arsenic exposure and the risk of cardiovascular diseases.

  2025cites this paper
• Relation of the non-high-density lipoprotein cholesterol to high-density lipoprotein cholesterol ratio to residual risk in anticoagulated patients with atrial fibrillation: a report from the prospective Murcia AF Project III cohort

  2025cites this paper
• Plasma NfL and cognitive functioning in older adults: The moderating role of HDL cholesterol

  2025cites this paper
• Association Between Cardiovascular Risk and Subclinical Atherosclerosis in Korean Female Patients with Systemic Lupus Erythematosus

  2025cites this paper
• APOA1 binding protein promotes lymphatic cell fate and lymphangiogenesis by relieving caveolae-mediated inhibition of VEGFR3 signaling

  2025cites this paper
• A multilayer network analysis of cardiovascular–depression comorbidity reveals symptom-specific molecular biomarkers

  2025cites this paper
• Potential of low apolipoprotein A-I as a surrogate marker of vulnerable carotid artery plaques.

  2025cites this paper
• High-density lipoprotein metrics during midlife and future subclinical atherosclerosis in women: the SWAN HDL study

  2024cites this paper
• The Essence of Lipoproteins in Cardiovascular Health and Diseases Treated by Photodynamic Therapy

  2024cites this paper
• Enhancing HDL Function to Prevent Atherothrombosis: Is it Time to Efflux the HDL Hypothesis?

  2024cites this paper
• Microvortex-induced turbulent mixing for reconstitution of high-density lipoprotein-mimicking nanoparticles with aggregation-prone phosphatidylcholine.

  2024cites this paper
• Cholesterol Efflux Capacity and Its Association with Oxidative Stress in Myocardial Infarction

  2024cites this paper
• Imbalance of APOB Lipoproteins and Large HDL in Type 1 Diabetes Drives Atherosclerosis

  2024cites this paper
• Effect of CSL112 on Recurrent Myocardial Infarction and Cardiovascular Death: Insights from the AEGIS-II Trial.

  2024cites this paper
• Impaired Cholesterol Uptake Capacity in Patients with Hypertriglyceridemia and Diabetes Mellitus.

  2024cites this paper
• HDL Therapeutics - Time for a Curtain Call or Time to Reconceptualize?

  2024cites this paper
• The Effect of Canagliflozin on High-Density Lipoprotein Cholesterol and Angiopoietin-Like Protein 3 in Type 2 Diabetes Mellitus

  2024cites this paper
• The Association of the Cholesterol Efflux Capacity with theParaoxonase 1 Q192R Genotype and the Paraoxonase Activity

  2024cites this paper
• LXR Agonist T0901317′s Hepatic Impact Overrules Its Atheroprotective Action in Macrophages, Driving Early Atherogenesis in Chow-Diet-Fed Male Apolipoprotein E Knockout Mice

  2024cites this paper
• Atherosclerosis Residual Lipid Risk-Overview of Existing and Future Pharmacotherapies

  2024cites this paper